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Background: Vitamin D status in the United States is a concern with over half of the population 
having insufficient serum 25(OH)D levels.  Vitamin D is essential for musculoskeletal 
mechanisms, which could lead to potential clinical issues within athletic populations. Examining 
the effects of serum 25(OH)D and vitamin D supplementation on musculoskeletal health and 
sports performance could alter the clinical approach toward the athletic population.  
Purpose: The purpose of this project is to: 1. evaluate the most current literature to determine, 
within the athletic population, the prevalence of insufficient serum 25(OH)D; 2.  determine the 
potential effects of insufficient serum 25(OH)D on athletic performance, bone and muscular 
health;  and  3. develop an appropriate protocol for vitamin D supplementation to be translated 
for clinical application and intervention.  
Methods: The Academy of Nutrition and Dietetics Evidence Analysis Process was used as a basis 
of methodology in determining the methods used for developing this literature review. The 
following electronic databases were searched to identify original peer-reviewed articles: 
PubMed, Google Scholar, and Collegiate and Professional Sports Dietitians Association (CPSDA) 
Research Library. Search words and key terms used in the search included “vitamin D”, 
“25(OH)D”, “athletes”, “performance”, “muscle mass”, “bone health”, “ethnicity”, 
“supplementation”.  Randomized- controlled trials, cohorts, cross sectional analysis as well as 
systematic reviews and meta-analysis studies using human subjects published between January 
2008 and October 2018 were included. Quality rating was assigned to studies to determine 
their “weight” in providing evidence for the research purpose. 
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Results: A total of 14 research studies were included in this literature review. There were a total 
of seven bone health, six muscular health, and eight performance and supplementation articles 
that matched the search criteria. Of the six bone health studies, four produced positive results 
on the relationship between 25(OH)D levels and stress fractures, bone mineral density, and 
bone turnover markers.  Of the six muscular health studies, five produced positive results on 
the relationship between 25(OH)D and muscle injury, strength and performance. Of the eight 
supplementation studies, six were found to have positive results of any dose of vitamin D 
treatment in increasing 25(OH)D levels. The remaining two studies suggested a low dose (daily 
200-4000 IU) only maintained 25(OH)D levels rather than increasing. Vitamin D3 was the form 
used in all studies with a vitamin D supplementation intervention. 
Conclusion: This literature review provides evidence of a positive impact of adequate serum 
25(OH)D levels on physical performance, bone and muscular health. Vitamin D 
supplementation may benefit those with adequate serum 25(OH)D levels, but provides more 
benefit to those who have insufficient or deficient serum 25(OH)D levels. Comparison of dose 
and daily versus weekly vitamin D supplementation benefits remain inconsistent. More 
research is necessary to determine the specific benefits of vitamin D supplementation and 
serum 25(OH)D levels, particularly regarding its effect on bone health.   
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Introduction 
Of the United States population, 77% are considered vitamin D insufficient, defined as 
25(OH)D levels are <30 ng/mL.1 The high prevalence may be the result of decreased sunlight 
during the winter months, malabsorption, darker skin color or the decreased ability to 
synthesize vitamin D with age. Vitamin D aids in various functions including mineral regulation 
and metabolic pathways, T cell activation, decreased inflammatory cytokines (IL-6,IL-8), and 
calcium, phosphate, and iron transportation and absorption. Each of these functions is 
regulated by interacting with the vitamin D receptor (VDR).2 The VDR is found in almost all body 
cells including immune, vascular, and smooth muscle cells. This explains why vitamin D plays an 
essential role for immune function, inflammatory response, bone and muscle health.  
Vitamin D insufficiency in athletes is an increasing concern as it may place them at 
higher risk for injury and negatively impact physical performance. Approximately 56% of the 
athletic population has vitamin D insufficiency (<32 ng/mL), according to a systematic review of 
twenty-three studies.3 Vitamin D status among athletes depends largely on geographical 
location and type of sports (indoor or outdoor). Risk factors for vitamin D deficiency include low 
dietary intake of vitamin D and limited ultraviolet (UV) exposure (sun) and/or absorption (such 
as dark skin pigmentation). Examining the effect of vitamin D may have on muscle strength, 
injury prevention and sports performance could alter the clinical approach toward the athletic 
population.  
Outline  
This review of literature will discuss: 
a) Measures of Vitamin D 
b) Differences in Ethnicity and Bioavailable Measures 
c) Effect on Bone Health 
d) Effect on Skeletal Muscle 
e) Effect on Physical Performance 
f) Effectiveness of Vitamin D Supplementation  
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Table 1. Review article inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria  
English Language  Animal Subject 
Human Subject In Vitro Study 
Published between 2008-2018 Published before 2008 
Sample Size >10 Sample Size <10 
Original peer-reviewed, randomized 
controlled, cohort, systematic review, meta-
analysis 
 
 
Measures of Vitamin D 
The currently accepted biomarker of vitamin D status is a blood test to measure total 
circulating 25-hydroxyvitamin D (25(OH)D) molecules.4 This measure is the most accurate 
indicator of vitamin D status because it takes account for UV exposure, dietary and 
supplemental intake, and has a long half life of approximately 3 weeks. It has shown to be a 
reliable marker that is used in a variety of inpatient and outpatient clinical settings to define 
vitamin D deficiency. The majority of circulating 25(OH)D is bound to a Vitamin D binding 
protein (DBP), which carries vitamin D in the blood and belongs to the albumin family. 
Circulating 25(OH)D bound to DBP extends its half-life even further by 15-35%.5 Although, DBP 
is not typically measured, recent research suggests some advantages.6 Individuals with low DBP 
also tend to have lower levels of total 25(OH)D related to the shorter half-life. In this case, 
bioavailable 25(OH)D (non-protein bound) levels may still be sufficient resulting in the absence 
of characteristics associated with insufficient vitamin D including hyperthyroidism, 
hypocalcemia or low bone mineral density (BMD). However, from a clinical perspective, 
bioavailable 25(OH)D would not reflect long-term overall status of vitamin D, which is why total 
25(OH)D is used to define vitamin D status. Consequently, research suggests DBP levels should 
be considered when analyzing total 25(OH)D as a biomarker. Levels of parathyroid hormone 
(PTH) can be an additional marker of vitamin D deficiency once low levels of 25(OH)D have 
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been established.4 PTH further assesses the severity of vitamin D insufficiency related to its role 
in calcium homeostasis and PTH secretion, with potential ramifications for bone health. Vitamin 
D is involved in regulating the amount of calcium in the blood, as serum calcium levels begin to 
drop PTH is released to increase calcium reabsorption from bone.  
There is a lack of consensus criteria for vitamin D deficiency and insufficiency. There is 
also a lack of agreement for recommended daily IU vitamin D intake. The Endocrine Society’s 
clinical guideline suggests 1,500 IU vitamin D daily is necessary to ensure a normal level of >30 
ng/mL.7 Deficiency is defined as <20 ng/mL and insufficiency as 21-29 ng/mL. On the other 
hand, the Vitamin D Council recommends maintaining serum levels of >50 ng/mL with intake of 
5,000 IU daily and serum 25(OH)D of <40 ng/mL being defined as deficient.8 The Institute of 
Medicine (IOM) suggests consumption of 600 IU of vitamin D daily to reach >20 ng/mL is 
generally considered sufficient for healthy individuals.9 They also propose serum levels of 
25(OH)D above 50 ng/mL have potential adverse effects. Certain individuals may require higher 
doses based on age, weight, and medical conditions such as malabsorption, digestive disorders 
and bariatric surgery.  
Table 2. Summary of General Population Vitamin D Recommendations 
 Endocrine Society Institute of Medicine  Vitamin D Council 
Adequate 30-100 ng/mL 20-60 ng/mL 40-150 ng/mL 
Insufficient 21-29 ng/mL 13-20 ng/mL 31-39 ng/mL 
Deficient <20 ng/mL <12 ng/mL <30 ng/mL 
Toxicity >10,000 IU daily >50 ng/mL 
>4,000 IU daily 
>150 ng/mL 
Daily 
Recommendation 
1,500 IU 600 IU 5,000 IU  
Treatment  50,000 IU weekly for 
8 weeks 
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Differences in Ethnicity and Bioavailable Measures  
Those with increased skin pigmentation, such as Asians and black Americans are more 
often diagnosed with vitamin D deficiency than white Americans.10 It has been suggested the 
increased melanin found in darker skin may slow vitamin D synthesis by two-thirds the rate of 
whites. A study involving 634 subjects found white females had the highest circulating 25(OH)D 
levels, while black males were the lowest with 70% considered deficient (<20 ng/mL).10 This 
same study also reported lower levels of 25(OH)D with higher levels of PTH, although bone 
health was not assessed. A later cohort study by Powe and colleagues, including 2085 subjects 
reported similar findings, although it did not include Asians.6 They also found lower levels of 
25(OH)D in black Americans compared to white Americans, which was inversely associated with 
increased levels of PTH regardless of race and ethnicity. However, this study also assessed 
BMD, which was higher in blacks than whites. Although blacks had higher levels of PTH, they 
also had higher levels of BMD. The authors concluded BMD and 25(OH)D were not correlated in 
blacks, but they were positively correlated in whites. A separate study of 1,200 female Navy 
recruits also found that although black Americans had the lowest mean 25(OH)D 
concentrations, their stress fracture risk was not significantly affected.11 These results raise an 
interesting clinical question as to whether circulating 25(OH)D affects calcium homeostasis and 
bone health in black Americans to the same extent it affects white Americans. 
 Further, lower levels of DBP have been observed in blacks. Interestingly, blacks are 
more likely to have a genetic single nucleotide polymorphism (SNP) of the DBP gene.6 
Deoxyribonucleic acid (DNA) is hereditary and stores important information that influences 
growth, function and development of all living organisms. SNPs occur in human genome and 
are variations in DNA between genes. This particular SNP results in lower levels of DBP and may 
explain the low levels of total 25(OH)D in individuals who carry this genetic polymorphism. This 
polymorphism could possibly mask vitamin D sufficiency.6 These findings together suggest total 
25(OH)D may not uniformly detect vitamin D deficiency from one ethnicity to another, and 
possibly from one individual to another, which needs to be considered when using total 
25(OH)D as a biomarker in a clinical setting. However, total 25(OH)D remains the accepted 
biomarker for vitamin D status and is used within research studies.  
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A 2015 study involving 80 National Football League (NFL) players reported black athletes 
had significantly lower vitamin D levels than the white athletes. In fact, 100% of the athletes 
deficient in vitamin D (<20ng/mL) were black and 91% of the athletes insufficient in vitamin D 
(20-32 ng/mL) were black.12 Among all NFL players in this study, 68.6% were either deficient or 
insufficient. A separate NFL study involving 214 athletes found that overall injury history among 
black players was inversely associated with lower vitamin D levels; however, the type of injury 
was not specified (muscular or skeletal).13 
Effect on Bone Health  
 As mentioned earlier, vitamin D plays a vital role in bone health by regulating calcium 
homeostasis together with PTH. With a lack of 25(OH)D, calcium absorption is reduced 
contributing to low levels of serum calcium.  To help restore calcium levels, PTH triggers the 
kidneys to increase the release of calcium from the bone and increase reabsorption of calcium 
from the kidneys. This vicious cycle of low 25(OH)D can lead to diminished BMD and overall 
bone health.7 Both calcium and vitamin D play a central role in bone formation and resorption. 
Cohort studies in postmenopausal women indicate that risk of fracture increases by a factor of 
1.4–2.6 for each standard deviation decrease in BMD.14 
Osteoporosis is diagnosed with a T-score of -2.5 or lower low bone mass is defined as a 
T-score between -1 and -2.5, and normal bone mass between 1 and -1 .15 A Z-score is 
recommended by the International Society of Clinical Densitometry to use with individuals 
under the age of 50, as it compares age and gender unlike T-Score. Athletes should have 10-
15% higher BMD than non-athletes, especially athletes in high-impact weight-bearing sports 
such as basketball, running, and soccer.16,17 The American College of Sports Medicine defines 
low BMD as a Z-Score between -1 and -2.17 Athletes who actively participate in non-weight- 
bearing sports such as swimming, cycling and rowing have consistently shown to have lower 
BMD. However, the National Collegiate Athletic Association (NCAA) reports stress fracture 
incidence in runners has been as high as 15%. An athlete with low BMD is at higher risk for 
stress reactions, stress fractures and bone injuries.  A stress reaction occurs prior to an actual 
stress fracture being present. Repeated stress on the bone results in the body’s inability to 
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efficiently form new bone (ossification) causing weakening of the bone. This repeated activity 
without sufficient rest time for repair can cause a stress fracture to form. In addition to low-
impact sport participation, stress fractures are commonly associated with sudden changes in 
activity intensity or frequency, low energy availability, amenorrhea, insufficient 25(OH)D levels, 
and low body mass index (BMI). Amenorrheic athletes have approximately 10% lower BMD, will 
lose 2-3% of their bone mass each year if left untreated, and have 2-4 times the increased risk 
for developing a stress fracture.17 All of these factors should be evaluated and treated if an 
athlete presents with a bone injury or low BMD.  
Maroon, et al12 reported a significant correlation between low levels of 25(OH)D and 
NFL players who had experienced one or more bone fractures, when controlling for the number 
of years played. A cohort study of 124 subjects reported an inverse association between stress 
fractures and 25(OH)D at ≤40 ng/mL.18  Further, a cohort study of 1,200 female Navy recruits 
reported those with 25(OH)D concentrations >40 ng/mL had half the risk of developing a stress 
fracture compared to those <20 ng/mL.11 It should be noted, only stress fracture data incidence 
for the tibia and fibula was gathered because these are the most common sites of injury in 
military recruits. In contrast, a study of 279 NBA players, reported 73.5% were vitamin D 
insufficient (20-32ng/mL) and found no association between vitamin D level and fracture 
history.19 However, the authors did not have access to any possible prior vitamin D 
supplementation.  
Effects on Skeletal Muscle 
Recent research suggests vitamin D may play a direct effect on skeletal muscle through 
the VDR in myocytes.2,6,20 This mechanism occurs through two pathways including a genomic 
and membrane signaling pathway. Binding of vitamin D to VDR may influence muscle function, 
contraction, and cell proliferation/differentiation. Because of the direct binding effect, an 
individual deficient in vitamin D may experience more immediate negative effects on muscle 
tissue before the bone.7 
A study of 214 football players in the NFL combine examined the association between 
the incidence of muscle injuries and 25(OH)D levels.13 Lower extremity muscle strains and core 
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muscle injuries were inversely associated with lower 25(OH)D levels. More specifically, marginal 
levels of 25(OH)D had an increased risk of lower extremity strain, core muscle injury and 
hamstring injury by 1.86 and 3.61, respectively. Similar muscle injury findings were discovered 
while monitoring 25(OH)D over a six-months among 32 collegiate swimmers and divers.21 The 
authors reported 77% of connective tissue and muscle injuries occurred after a noted decrease 
in 25(OH)D levels. Interestingly, no bone injuries were reported, although skeletal injuries are 
less common in non-weight bearing sports.  
A cross sectional study of 419 men and women (20-76 years) explored the relationship 
between serum 25(OH)D and muscle strength.22 A significant positive correlation between 
25(OH)D levels and both upper and lower muscle strength was observed when controlling for 
age and gender. A separate meta-analysis review of seven trials included 310 male and female 
adults (18-40 years old) and examined the effects of vitamin D supplementation on muscle 
strength, by assessing leg press, squats, chest press, bench press, and grip strength.23 Mean 
baseline 25(OH)D  was 12.3 ng/mL among all subjects. Vitamin D was supplemented from 4,000 
IU per day to 60,000 IU per week; however, 25(OH)D levels were not monitored throughout the 
trial. Regardless, vitamin D supplementation was positively associated with a significant 
increase in both upper and lower strength.  
Vitamin D Supplementation and Physical Performance 
Once vitamin D insufficiency or deficiency in an athlete is identified, an optimal dose to 
elicit potential benefits of supplementations needs to be determined. Vitamin D3 supplements 
(compared with D2) have been shown to have the greatest impact on increasing the 
concentration of serum 25(OH)D due to high binding affinity to DBP.24 Debate remains 
regarding the required dose of vitamin D supplementation. This debate exists as it relates to 
varying daily dose and optimal levels set forth by the IOM, The Endocrine Society and Vitamin D 
Council.6-8 Further, individuals may respond differently to the same dosing regimen, suggesting 
there may not be an all-inclusive protocol. Although a daily dose may provide more stable 
concentrations of circulating vitamin D, some clinical trials use a weekly dose rather than daily 
to fully validate compliance of subjects. Due to this inconsistency, vitamin D supplementation 
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widely varies in dose and frequency. Common supplementation ranges from 2,000-5,000 IU 
daily or 35,000-70,000 IU weekly.  
In one study, 42 athletes received either 35,000 or 70,000 IU of vitamin D3 per week for 
12 weeks and were monitored for a total of 18 weeks.25 The purpose of this study was to 
monitor the response of high dose supplementation (>35,000 IU/week) on vitamin D 
metabolites and potential withdrawal effects. More specifically, 24,25[OH]2D was monitored 
because a higher production of this vitamin D metabolite may decrease 25(OH)D 
concentrations. Both intervention groups had a significant increase in 25(OH)D and decrease in 
PTH by week six. However, by week 18 both the low and high dose supplemental groups had 
returned to baseline 25(OH)D measurements. The 24,25[OH]2D metabolite also increased 
throughout the intervention and remained significantly higher than baseline (p<0.05) at week 
18. Interestingly, these findings indicate this metabolite may inhibit the activity of VDR; 
however, more research in this area is needed. Therefore, Owens and colleagues suggest a 
lower more frequent dose of vitamin D3, with a gradual withdrawal, may be the most ideal 
intervention.25 In contrast, Tomlinson and colleagues suggest daily D3 supplementation and 
larger weekly doses have the same effectiveness regarding improving muscle strength.23 Their 
meta-analysis of seven studies show consistent significant results of daily supplementation 
compared to conflicting results of weekly dose. 
Vitamin D supplementation and physical performance has been assessed in a 
randomized placebo-controlled cohort study of athletes.26 Baseline 25(OH)D was measured and 
suggested 70% of the subjects had insufficient 20(OH)D levels of <20 ng/mL. The intervention 
group received a daily dose of 5,000 IU vitamin D supplementation for eight weeks. This group 
demonstrated a significant improvement in the vertical jump and sprint performance protocols, 
while the placebo group exhibited no change. In a smaller randomized control trial of 30 male 
and female subjects, the effect of vitamin D supplementation on muscle power strength was 
observed. Of these 30 subjects, 37% exhibited 25(OH)D insufficiency at baseline (<30 ng/ml).27 
All subjects were randomly assigned to receive supplements of either 200 IU, 4,000 IU, or 
placebo for 28 consecutive days. Muscle power strength was assessed by a single leg plyo-
press. Findings suggest 25(OH)D levels were positively correlated with muscle strength, but 
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supplementation among the 63% of subjects who were 25(OH)D sufficient (≥ 30 ng/ml) did not 
improve muscle strength.  
In a later review by Tomblinson et al23, vitamin D supplementation was also shown to 
increase muscle strength in those who were 25(OH)D deficient (≤ 32 ng/ml). Interestingly, a 
randomized dose-response study of 30 athletes supplemented with either placebo, 20,000 IU 
or 40,000 IU for 12 weeks found no correlation between 25(OH)D concentrations above 50 
ng/ml and physical performance and muscle strength as measured by bench press, leg press 
and vertical jump height.28 Cumulatively, these findings suggest a plateau of 25(OH)D in further 
improving muscle strength when serum 25(OH)D levels are sufficient.  
Prolonged intense physical activity training can result in excessive bone turnover and 
incidence of stress fractures. The negative impact of vitamin D insufficiency on bone health 
through the calcium homeostasis mechanism presents additional high risk for bone fracture 
injury. In a randomized double-blind placebo controlled study, supplementation containing 
both vitamin D3 (800 IU/day) and calcium (2000 mg/day) for 8 weeks was shown to decrease 
stress fracture incidence in 3,700 female Navy recruits aged 17-35 years of age.29 
Unfortunately, this study examined vitamin D3 and calcium together, not separately.  
A more recent study examined the effects of vitamin D supplementation on bone 
turnover in 68 adolescent females who presented with low 25(OH)D (<20 ng/mL) at baseline.30 
All subjects received weekly vitamin D3 supplementation of 35,000 IU for four weeks. Although 
there was not a placebo group, there was an overall significant increase in 25(OH)D levels from 
baseline of 11.2 ± 6 ng/mL to 22.4 ± 9.2 ng/mL by the end of the study. In addition, PTH and 
bone turnover markers (BTMs) of osteocalcin and carboxy-terminal telopeptides of crosslinks of 
type 1 collagen (βCTX) significantly decreased in just four weeks. During bone resorption, βCTX 
is released into the bloodstream and can serve as a biomarker of bone degradation. Elevated 
βCTX may indicate increased bone resorption during times of growth or fracture healing. 
However, the role of vitamin D supplementation for fracture healing has produced conflicting 
evidence in the literature based on a review of 105 articles by Gorter and  colleagues.31 Articles 
published between the years 1984-2013 were gathered to explore the cellular effects and 
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clinical involvement of vitamin D in fracture healing. The researchers used four identifying 
characteristics when reviewing these articles including biomarkers of inflammation (IL-6), soft 
callus formation (IGF), hard callus formation (collagen 1), and remodeling (osteoclastogenesis). 
Each of these areas explored produced conflicting results. Thus, it is critical that vitamin D 
status in athletes (as well as other populations) are evaluated and supplementation is initiated 
as appropriate for a more proactive approach in preventing injury occurrence.  
With any dietary supplementation, toxicity and adverse effects must be carefully 
considered and monitored. Vitamin D toxicity from sunlight or dietary intake has never been 
reported.5 Vitamin D toxicity is more likely to occur from the overuse of supplementation or by 
faulty manufactured supplements. Symptoms of toxicity include hypercalcemia, frequent 
urination, excessive thirst, anorexia nausea, vomiting and possibly altered mental status. 
Research is mixed on kidney stone formation in relationship to high vitamin D levels.6,32,33 This is 
most likely due to the many other possible contributing factors to stone formation such as age, 
dehydration, obesity, and certain medications (diuretics, antibiotics). However, many kidney 
stones are calcium based and could be impacted by high levels of vitamin D due to vitamin D’s 
involvement in calcium homeostasis. It is crucial that individuals have their vitamin D checked 
prior to supplementation and routinely to provide treatment efficacy and to reduce the risk of 
adverse events. 
A randomized clinical trial put forth by the Women’s Health Initiative (WHI) found a 
positive correlation between urinary tract stone incidence with the use of calcium plus vitamin 
D supplements. ExaminationVitamin D only supplementation was not conducted.32 A separate 
study that did analyze vitamin D status relative to kidney stone formation found 25(OH)D levels 
between 20-100 ng/mL were not associated with increased kidney stone incidence.33 The same 
study reported positive correlations between BMI and age with kidney stone development, 
which is less likely a concern within an athletic population. Overall, toxicity levels and adverse 
effects of vitamin D are unlikely. No adverse effects have been reported with 70,000 IU weekly 
supplementation.24 A no adverse effect limit (NOAEL) of 10,000 IU daily has been noted by the 
Institute of Medicine (IoM).8  
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Conclusion 
Vitamin D has many important functions including calcium homeostasis, PTH regulation, bone 
and muscle health. The risk of vitamin D insufficiency in athletes is not only an expanding area 
of interest in research, but it is a growing topic in the sports medicine and sports nutrition fields 
with physical performance a top priority. Current evidence suggests increasing serum 25(OH)D 
levels may have beneficial effects on bone and muscle health in those who have depleted 
stores, while the evidence remains unclear of the same benefits for increasing already sufficient 
25(OH) levels.17,24-27 Higher serum levels of vitamin D seem to overall be inversely associated 
with reduced injury rates and improved sports performance. Sun UV exposure is the primary 
source of Vitamin D and can be difficult to accurately account for, thus will often confound 
findings when assessing response to vitamin D supplementation. It is crucial that this UV 
exposure be considered in clinical settings. There remains controversy on the topic of vitamin D 
and there is a need for clarity and standardization of levels defining vitamin D deficiency and 
insufficiency as well as a protocol for appropriate supplement dosage. Without this 
standardization, replicable research is a significant challenge. At the same time, standardization 
is a difficult development without the replicable research. Once gold standard methods are 
developed, supplement protocol and serum values can be directly comparable between studies 
and clinical settings. In addition to standardization, future research should control for co-
founding variables such as UV exposure, supplement compliance, sport type (weight bearing 
versus non weight bearing), playing time, and baseline 25(OH)D concentrations. 
 
 
 
 
 
Table 3. Excluded Articles 
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Excluded Articles Reason for Exclusion  
Safadi FF, et al., Osteopathy and resistance to 
vitamin D toxicity in mice null for vitamin D 
binding protein, 1999. 
Date, non-human subject  
Gorter EA, et al., The role of vitamin D in 
human fracture healing: A systematic review 
of the literature, 2014. 
In Vitro  
Meier C,et al., Supplementation with Oral 
Vitamin D3 and Calcium During Winter 
Prevents Seasonal Bone Loss: A Randomized 
Controlled Open-Label Prospective Trial, 
2004  
Published before 2008 
 
Table 4. Summary of Bone Health Studies   
Study 
Author/Year/Desig
n 
Study 
Population 
Methods and 
Intervention 
Measured 
Markers 
Significant Outcomes  
Maroon et al., 2015, 
cohort  
80 NFL male 
athletes aged 
26.5±3.7 yr 
25(OH)D 
measured to 
compare race 
and BF reports 
over 2 yr 
25(OH)D 
(≥32=sufficient, 
≤20=deficient), 
BMD, 
BF hx 
25(OH)D of blacks 
significantly lower than 
whites. 25(OH)D 
significantly lower in 
players with hx of 1+ BF 
Miller, et al., 2016, 
retrospective Cohort 
124 male 
(n=42) and 
female (n=82) 
subjects aged 
43.9±17.5 yr 
Examine 25(OH)D 
levels in pts with 
SF 
25(OH)D, SF 83% of pts had 25(OH)D 
levels <40 ng/mL 
Burgi, et al., 2011, case-
control cohort 
1,200 female 
Navy recruits 
aged 19.5 ± 
1.7 yr 
Determine 
25(OH)D level 
with greatest risk 
of SF 
25(OH)D, tibia and 
fibula  SF 
Half the risk of SF in those 
with 25(OH)D  >40ng/mL 
compared to those with 
<20 ng/mL 
Grieshober, et al., 
2018, epidemiology 
study 
279 NBA 
combine male 
athletes with 
Data obtained 
and analysed to 
determine 
associations 
25(OH)D (≥30= 
sufficient, 20-29= 
insufficient, ≤20= 
deficient), bone SF 
25(OH)D deficiency in 
32.3%, insufficiency in 
41.2%, and sufficient 
levels in 26.5% of subjects. 
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a mean age of 
21.5 yr  
between vit D 
status, SF risk 
and NBA draft 
status  
hx, NBA draft 
status 
25(OH)D  not predictive of 
SF risk. Pts with deficient 
25(OH)D had a 
significantly lower rate of 
NBA draft. NBA draft rate 
increased with increasing 
25(OH)D levels 
Lewis et al., 2013, 
randomized placebo 
controlled 
32 male and 
female (41%) 
swimmers 
aged 19-21 yr 
with 25(OH)D 
⪰32ng/mL 
6 mo. vit D 
supplement 
(4,000 IU (n=19) 
or PLA (n=13) 
25(OH)D 
(≥32=sufficient, 
≤20=deficient), 
BMD, IL6 
16% dropped below 
32ng/mL (n=1 VIT D, n=4 
PLA). Mean changes in 
25(OH)D were +1ng/mL 
(VIT D) and -20ng/mL 
(PLA). No significant 
findings of BMD or IL6 
Lappe et al., 2008, 
randomized double-
blind, placebo 
controlled 
3700 female 
navy recruits 
median aged 
19 yr 
Daily vit D (800 
IU) and calcium 
(2000mg) 
supplement 
(n=1852) or PLA 
(n=1848) for 8 wk 
SF incidence  Treatment group had 21% 
lower incidence of SF 
compared to PLA.  
Sulimani et al., 2017, 
cohort interventional 
study 
68 females vit 
D deficient 
aged 15.1  ± 
1.7 yr 
Weekly 35000 IU 
vit D supplement 
for 4 wk 
25(OH)D 
(≤20=deficient), 
PTH, βCTX, 
osteocalcin 
Significant increase in 
25(OH)D, significant 
decrease in PTH, 
osteocalcin and βCTX  
 
List of Abbreviations: yr= years; 25(OH)D= 25-hydroxyvitamin D; BF= bone fracture; hx= history; pts= patients; SF= 
stress fracture; vit D= vitamin D; PLA= placebo; mo.= months; BMD= bone mineral density; IL6= interleukin 6; wk= 
weeks 
Table 5. Summary of Muscular Health Studies  
Study 
Author/Year/Design 
Study 
Population 
Methods and 
Intervention 
Measured 
Markers 
Significant Outcomes 
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Rebolledo et al., 2018, 
retrospective Cohort  
214 NFL male 
athletes aged 
26.6±4.5 yr 
25(OH)D, Race, 
and MI collected to 
compare 
associations  
25(OH)D ( ≥32= 
sufficient, 20-31= 
insufficient, ≤20= 
deficient), 
MI hx, race 
Insufficient 25(OH)D found 
in 49% of pts and 10% with 
deficiency. Black race and 
MI was associated with 
lower 25(OH)D levels  
Grimaldi et al., 2014, 
cross sectional  
419 male 
(48%) and 
female (52%) 
ages 20-76 yr 
Investigate the 
relation of vit D 
status and arm and 
leg Isometric and 
isokinetic strength 
using 
computerized 
dynamometry  
25(OH)D, hand 
grip,  elbow and 
knee 
flexion/extension 
25(OH)D significantly 
positively correlated with 
isometric and isokinetic arm 
strength and isometric leg 
MS when controlling age 
and gender 
Tomlinson, et al. 2015, 
systematic review with 
meta-analysis 
310 male and 
female (67%) 
aged 18-40 yr, 
mean ages 
from 21.5 to 
31.5 yr 
Included 7 RCT 
lasting 4 wk-6 mo. 
25(OH)D, vit D 
supplement (4000 
IU/d-60000 IU/wk, 
upper and lower 
limb MS 
All doses of vit D 
significantly increased MS 
of both upper and lower 
limbs.  
Close et al., 2013, 
double-blind placebo-
controlled  
10 male 
soccer 
athletes aged 
18 yr  
5000 IU daily vit D 
supplement (n=5) 
or PLA (n=5) for 8 
wk 
 25(OH)D 
(≥40=sufficient,≤2
0=deficient), 
bench press, 
squat, sprint, 
vertical jump 
Sprint times, vertical jump, 
25(OH)D significantly 
increased in the vit D group.  
Barker, et al., 2012, 
randomized double-
blind placebo-
controlled 
30 male and 
female (n=15) 
aged 18-45 yr 
Daily 4000 IU vit D 
(HD), 200 IU vit D 
(LD), or PLA for 28 
days 
25(OH)D 
(≥30=sufficient, 
≤20=deficient ), 
IL6, MS (leg) 
63% of pts vit D sufficient at 
BL. 25(OH)D and IL6 
decreased in PLA. LD 
maintained 25(OH)D, 
increased IL6. HD increased 
25(OH)D, maintained IL6. 
25(OH)D associated with 
MS, not supplementation 
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Close et al., 2013, block 
randomized dose-
response 
30 male 
athletes aged 
20-24 yr 
Weekly 20000 IU 
(LD), 40000 IU 
(HD), or PLA  for 12 
wk. All groups 
included 10 
subjects.  
25(OH)D(≤20= 
deficient), bench 
press, leg press, 
vertical jump 
57% of pts 25(OH)D 
deficient at BL. 25(OH)D 
increased in LD and HD 
groups to achieve 
>20ng/mL, decreased in 
PLA. No effect on physical 
performance markers 
List of Abbreviations: yr= years; 25(OH)D= 25-hydroxyvitamin D; MI= muscle injury; hx= history; pts= patients; vit 
D= vitamin D; MS= muscle strength; wk= weeks; RCT= randomized control trial; mo.= months; PLA= placebo; IL6= 
interleukin 6; BL= baseline; HD= high dose; LD= low dose 
Table 6. Summary of Vitamin D Supplementation Studies  
Study 
Author/Year/Design 
Study 
Population 
Methods and 
Intervention 
Measured 
Markers 
Significant  
Outcomes 
Lewis et al., 2013, 
randomized placebo 
controlled 
32 male and 
female (41%) 
swimmers 
aged 19-21 yr 
with 25(OH)D 
⪰32ng/mL 
6 month daily vit D 
supplement (4,000 
IU (n=19) or PLA 
(n=13) 
25(OH)D 
(≥32=sufficient, 
≤20=deficient), 
BMD, IL6 
16% dropped below 
32ng/mL (n=1 Vit D, n=4 
PLA). Mean changes in 
25(OH)D were +1ng/mL (Vit 
D) and -20ng/mL (PLA).  
Tomlinson, et al. 2015, 
systematic review with 
meta-analysis 
310 male and 
female (67%) 
aged 18-40 yr 
Seven RCT lasting 4 
wk-6 mo. Vit D 
supplement of 
4000 IU/d-60000 
IU/wk 
25(OH)D, MS: 
grip, bench press, 
chest press, leg 
press, squats 
All doses of vit D 
significantly increased MS of 
both upper and lower limbs.  
Owens, et al., 2017, 
block randomized  
42 male elite 
athletes 26 ± 3 
yr 
Block randomized 
on BL 25(OH)D into 
either 70000 IU 
(HD) or 35000 IU 
(LD) weekly vit D 
supplement for 12 
wk, monitored for 
18 wk 
25(OH)D, PTH, 
24,25[OH]2D, 
1,25[OH]2D3 
All  doses had significant 
increases in 25(OH)D and 
1,25[OH]2D3 . HD 
significantly increased 
24,25[OH]2D. PTH 
decreased in both groups. 
LD recommended.  
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Close et al., 2013, 
double-blind placebo-
controlled  
10 male soccer 
athletes aged 
18 yr  
5000 IU daily vit D 
supplement (n=5) 
or PLA (n=5) for 8 
wk 
 25(OH)D 
(≥40=sufficient,≤
20=deficient), 
bench press, 
squat, sprint, 
vertical jump  
Sprint times, vertical jump, 
25(OH)D significantly 
increased in the vit D group.  
Barker, et al., 2012, 
randomized double-
blind placebo-
controlled 
30 male and 
female (n=15) 
aged 18-45 yr 
Daily 4000 IU vit D 
(HD), 200 IU vit D 
(LD), or PLA for 28 
days 
25(OH)D 
(≥30=sufficient, 
≤20=deficient), 
IL6, MS (leg) 
63% of pts vit D sufficient at 
BL. 25(OH)D and IL6 
decreased in PLA. LD 
maintained 25(OH)D, 
increased IL6. HD increased 
25(OH)D, maintained IL6. 
25(OH)D associated with 
MS, not supplementation 
Close et al., 2013, block 
randomized dose-
response 
30 male 
athletes aged 
20-24 yr 
Weekly 20000 IU 
(LD), 40000 IU 
(HD), or PLA  for 12 
wk. All groups 
included 10 
subjects.  
25(OH)D(≤20 
ng/mL= 
deficient), bench 
press, leg press, 
vertical jump 
57% of pts 25(OH)D 
deficient at BL. 25(OH)D 
increased in LD and HD 
groups to achieve 
>20ng/mL, decreased in 
PLA. No effect on physical 
performance markers 
Lappe et al., 2008, 
randomized double-
blind, placebo 
controlled 
3700 female 
navy recruits 
median aged 
19 yr 
Daily vit D (800 IU) 
and calcium 
(2000mg) 
supplement(n=185
2) or PLA (n=1848) 
for 8 wk 
SF incidence  Treatment group had 21% 
lower incidence of SF 
compared to PLA.  
Sulimani et al., 2017, 
cohort interventional 
study 
68 females vit 
D deficient 
(<20 ng/mL) 
aged 15.1  ± 
1.7 yr.  
Weekly 35000 IU 
vit D supplement 
for 4 wks 
25(OH)D 
(≤20=deficient), 
PTH, βCTX, 
osteocalcin 
Significant increase in 
25(OH)D, significant 
decrease in PTH, osteocalcin 
and βCTX  
List of Abbreviations: yr= years; 25(OH)D= 25-hydroxyvitamin D; vit D= vitamin D; PLA= placebo; BMD= bone 
mineral density; IL6= interleukin 6; RCT= randomized control trial; wk= weeks; mo.= months; MS= muscle strength; 
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BL= baseline; HD= high dose; LD= low dose; PTH= parathyroid hormone; 24,25[OH]2D,= 24,25-dihydroxyvitamin D; 
1,25[OH]2D3  =1,25-dihydroxyvitamin D; SF= stress fracture; βCTX= C-terminal telopeptide 
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